|
Sign In to gain access to subscriptions and/or personal tools.
|
Effect of Benzodiazepines on Tryptophan Binding to Rat Hepatic Nuclei
Herschel Sidransky
Department of Pathology, The George Washington University Medical Center, Washington, D.C. 20037
Ethel Verney
Department of Pathology, The George Washington University Medical Center, Washington, D.C. 20037
James W. Cosgrove
Department of Pathology, The George Washington University Medical Center, Washington, D.C. 20037
Arnold M. Schwartz
Department of Pathology, The George Washington University Medical Center, Washington, D.C. 20037
This study evaluates whether or not some of the benzodiazepines would influence the binding of L-tryptophan to rat hepatic nuclei or nuclear envelopes. Previous publications have indicated that binding of L-tryptophan to hepatic nuclear envelope proteins was saturable, stereospecific, and of high affinity. In this study, we investigated whether some of the benzodiazepines would influence L-tryptophan binding to rat hepatic nuclei or nuclear envelopes as assayed by in vitro L-(5-3H) tryptophan binding. Our results indicate that the addition of chlordiazepoxide, diazepam, prazepam, flurazepam, nordazepam, N-desalkylflurazepam, temazepam, oxazepam, lorazepam, or 4-chlorodiazepam has little influence on the L-(5-3H) tryptophan binding to hepatic nuclei in vitro. However, the addition of demoxepam, the N-desalkylated compound of chlordiazepoxide, caused marked competition with 3H-tryptophan binding to hepatic nuclei in vitro. When chlordiazepoxide (1 mg/100 g body weight) is administered intraperitoneally 20 min before killing, the isolated hepatic nuclei reveal decreased specific L-tryptophan binding compared to controls. Also, rats pretreated with chlordiazepoxide intraperitoneally before tube-feeding L-tryptophan revealed diminished tryptophan-induced hepatic nuclear RNA efflux and protein synthesis. Our results suggest that chlordiazepoxide, possibly by itself or through a metabolite, can act to affect hepatic nuclear binding of L-tryptophan and to inhibit the stimulatory effect of L-tryptophan on hepatic protein synthesis.
Key Words: Receptor binding nuclear envelopes protein synthesis
- Agutter PS and Gleed CD (1980). Variability of mammalian liver nuclear envelope preparations. Biochem. J. 192: 85-89.[Web of Science][Medline]
[Order article via Infotrieve]
- Agutter PS, McArles HJ, and McCaldin B. (1976). Evidence for involvement of nuclear envelope nucleoside triphosphatase in nucleocytoplasmic translocation of ribonucleoprotein. Nature 263: 165-167.[CrossRef][Medline]
[Order article via Infotrieve]
- Blobel G. and Potter VR (1966). Nuclei from rat liver: Isolation method that combines purity with high yield. Science 154: 1662-1665.[Abstract/Free Full Text]
- Braestrep C. and Nielsen M. (1983). Benzodiazepine receptors. In: Handbook of Psychopharmacology, Vol. 17, Biochemical Studies of CNS Receptors, LL Iversen, SD Iversen, and SH Snyder (eds). Plenum Press, New York, pp. 285-384.
- Centers for Disease Control ( 1990). Analysis of L-tryptophan for the etiology of ecosinophilia-myalgia syndrome. Morb. Mortal. Wkly. Rep. 39: 589.[Medline]
[Order article via Infotrieve]
- Cosgrove JW, Verney E., and Sidransky H. (1991). Tryptophan binding to rat brain nuclei. FASEB J. 5: A1318.
- Crofford LJ, Rader JI, Dalakas MC, Hill RH Jr, Page SW, Needham LL, Brody LS, Heyes MP, Wilder RL, Gold PW, Illa I., Smith C., and Sternberg EM (1990). L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat. J. Clin. Invest. 86: 1757-1763.[Web of Science][Medline]
[Order article via Infotrieve]
- Denckla WD and Dewey HK (1967). The determination of tryptophan in plasma, liver, and urine. J. Lab. Clin. Med. 69: 160-169.[Web of Science][Medline]
[Order article via Infotrieve]
- Fehske KJ, Muller WE, and Wollert U. (1979). A highly reactive tyrosine residue as part of the indole and benzodiazepine binding site of human serum albumin. Biochim. Biophrs. Acta 577: 346-359.
- Folkerth RD, Solomon CG, and Sotrel A. (1990). Eosinophilia-myalgia syndrome: Histopathologic features. J. Neuropathol. Exp. Neurol. 49: 315.
- Gacad G., Dickie K., and Massaro D. (1972). Protein synthesis in lung: Influence of starvation on amino acid incorporation into protein. J. Appl. Physiol. 33: 381-384.[Free Full Text]
- Harris JR and Milne JF (1974). Rapid procedure for isolation and purification of rat-liver nuclear envelope. Biochem. Soc. Trans. 2: 1251-1253.[Web of Science]
- Herrick MK, Chang Y., Horoupian DS, Lombard CM, and Adornato BT (1991). L-tryptophan and the eosinophilia-myalgia syndrome: Pathologic findings in eight patients. Hum. Pathol. 22: 12-21.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hertzman PA, Blevins WL, Mayer J., Greenfield B., Ting M., and Gleich GJ (1990). Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N. Engl. J. Med. 322: 869-873.[Abstract]
- Hertzman PA, Falk H., Kilbourne EM, Page S., and Shulman LE (1991). The eosinophilia-myalgia syndrome: The Los Alamos conference. J. Rheumatol. 18: 867-873.[Web of Science][Medline]
[Order article via Infotrieve]
- Jorgensen AJF and Majumdar APN (1976). Bilateral adrenalectomy: Effect of tryptophan force-feeding on amino acid incorporation into ferritin, transferrin, and mixed proteins of liver, brain and kidneys in vivo. Biochem. Med. 16: 37-46.[Medline]
[Order article via Infotrieve]
- Kamb ML, Murphy JJ, Jones JL, Caston JC, Nederlof K., Homey LF, Swygert LA, Falk H., and Kilbourne EM (1992). Eosinophilia-myalgia syndrome in L-tryptophan-exposed patients. JAMA 267: 77-82.[Abstract/Free Full Text]
- Kragh-Hansen U. (1981). Molecular aspects of ligand binding to serum albumin. Pharmacol. Rev. 33: 17-53.[Web of Science][Medline]
[Order article via Infotrieve]
- Kragh-Hansen U. (1983). Graphical analysis of competitive binding of comparable concentrations of ligand, inhibitor and protein. Ligand binding to serum albumin. Biochem. Pharmacol. 32: 2679-2681.
- Kragh-Hansen U. (1983). Relations between high-affinity binding sites for L-tryptophan, diazepam, salicylate and Phenol Red on human serum albumin. Biochem. J. 209: 135-142.[Web of Science][Medline]
[Order article via Infotrieve]
- Kurl RN, Verney E., and Sidransky H. (1987). Tryptophan-binding sites on nuclear envelopes of rat liver. Nutr. Rep. Int. 36: 669-677.[Web of Science]
- Kurl RN, Verney E., and Sidransky H. (1988). Identification and immunohistochemical localization of tryptophan binding protein in nuclear envelopes of rat liver. Arch. Biochem. Biophys. 265: 286-293.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Love LA, Rader JI, Crofford LJ, Page SW, Hill RH, Raybourne RB, and Sternberg EM (1991). L-tryptophan (L-TRP) and 1,1'-ethylidenebis(tryptophan) (EBT), a contaminant in eosinophilia myalgia syndrome (EMS) case-associated L-TRP, cause myofascial thickening and pancreatic fibrosis in Lewis rats. Arthritis & Rheum. 34: S131, B201.
- Lowry OH, Rosebrough MR, Farr AL, and Randall RJ (1951). Protein measurement with Folin phenol reagent. J. Biol. Chem. 193: 265-275.[Free Full Text]
- Majumdar APN (1982). Effects of fasting and subsequent feeding of a complete or tryptophan-free diet on the activity of DNA-synthesizing enzymes and protein synthesis in gastric mucosa of rats. Ann. Nutr. Metab. 26: 264-272.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mayeno AN, Lin F., Foote CS, Loegering DA, Ames MM, Hedberg GW, and Gleich GJ (1990). Characterization of "peak E", a novel amino acid associated with eosinophilia-myalgia syndrome. Science 250: 1707-1708.[Abstract/Free Full Text]
- Muller WE and Wollert U. (1975). Benzodiazepines: Specific competitors for the binding of L-tryptophan to human serum albumin. Naunyn-Schmiedeberg's Arch. Pharmacol. 288: 17-27.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Murty CN, Verney E., and Sidransky H. (1977). The effect of tryptophan on nucleocytoplasmic translocation of RNA in rat liver. Biochim. Biophys. Acta 474: 117-128.[Medline]
[Order article via Infotrieve]
- Murty CN, Verney E., and Sidransky H. (1979). In vivo and in vitro studies on the effect of tryptophan on translocation of RNA from nuclei of rat liver. Biochem. Med. 22: 98-109.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Rommelspacher H., Nanz C., Borbe HO, Fehske KJ, Muller WE, and Wollert U. (1980). 1-Methyl-betacarboline (harmane), a potent endogenous inhibitor of benzodiazepine receptor binding. Naunyn-Schmeideberg's Arch. Pharmacol. 314: 97-100.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sakimoto K. (1990). The cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N. Engl. J. Med. 323: 992-993.[Web of Science][Medline]
[Order article via Infotrieve]
- Schumm DS and Webb TE (1974). Modified messenger ribonucleic acid release from isolated nuclei after inhibition of polyadenylate formation. Biochem. J. 139: 191-196.[Web of Science][Medline]
[Order article via Infotrieve]
- Sidransky H. (1985). Tryptophan: Unique actions by an essential amino acid. In: Nutritional Pathology. Pathobiology of Dietary Imbalances, H Sidransky (ed). Marcel Dekker, New York, pp. 1-62.
- Sidransky H., Sarma DSR, Bongiorno M., and Verney E. (1968). Effect of dietary tryptophan on hepatic polyribosomes and protein synthesis in fasted mice. J. Biol. Chem. 243: 1123-1132.[Abstract/Free Full Text]
- Sidransky H., Verney E., Cosgrove J., and Schwartz AM (1992). Inhibitory effect of demoxepam on tryptophan binding to rat hepatic nuclei. Biochem. Med. Met. Biol. 47: 270-273.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sidransky H., Verney E., and Sarma DSR (1971). Effect of tryptophan on polyribosomes and protein synthesis in liver. Am. J. Clin. Nutr. 24: 779-785.[Abstract]
- Silver RM, Heyes MP, Maize JC, Quearry B., Vionnet-Fuasset M., and Sternberg EM (1990). Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan. N. Engl. J. Med. 332: 874-881.
- Sjoholm I., Ekman B., Kober A., Ljungstedt-Pahlman I., Seiving B., and Sjodin T. (1979). Binding of drugs to human serum albumin: XI. The specificity of three binding sites as studied with albumin immobilized in microparticles. Mol. Pharmacol. 16: 767-777.[Abstract/Free Full Text]
- Snedecor GW and Cochran WG (1980). Statistical Methods. Iowa State University Press, Ames, pp. 215-236.
- Swygert LA, Maes EF, Sewell LE, Miller L., Falk H., and Kilbourne EM (1990). Eosinophilia-myalgia syndrome. Results of national surveillance. JAMA 264: 1698-1703.[Abstract/Free Full Text]
- Tazelaar HD, Myers JL, Drage CW, King TE Jr, Aguayo S., and Colby TV (1990). Pulmonary disease associated with L-tryptophan induced eosinophilia myalgia syndrome: Clinical and pathologic features. Chest 97: 1032-1036.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Verity MA, Bulpitt KJ, and Paulus HE (1991). Neuromuscular manifestations of L-tryptophan-associated eosinophilia-myalgia syndrome: A histomorphologic analysis of 14 patients. Hum. Pathol. 22: 3-11.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
Toxicologic Pathology, Vol. 20, No. 3-1,
350-356 (1992)
DOI: 10.1177/019262339202000305

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|